Oxygen interruption leads to death when reoxygenation is not promptly re-established. Re-oxygenation triggers a cascade of biochemical events for restoring function at the cost of improper homeostasis. The effects observed long after perinatal asphyxia (PA) have been explained by over-expression of sentinel proteins, such as poly(ADP-ribose) polymerase-1 (PARP-1), competing for NAD+ during re-oxygenation, leading to the idea that sentinel protein inhibition constitutes a therapeutic strategy. We studied the effects of nicotinamide and theophylline on PARP-1 activity assayed in brain and peripheral (heart) rat tissue 1-24 h after birth, as well as on changes in behaviour and monoamine neurotransmission in adult rats. PA was induced by immers...
The potential neuroprotection of nicotinamide on the consequences of perinatal asphyxia was invest...
Background. Hypoxia ischemia (HI) to the developing brain occurs in 1–6 in 1000 live births. Large ...
Aminophylline is widely used in the management of premature apnea. The methylxanthines aminophylline...
© 2015, The Author(s).Perinatal asphyxia (PA) is a leading cause of neuronal damage in newborns, res...
We have investigated the idea that nicotinamide, a non-selective inhibitor of the sentinel enzyme Po...
Delivery is a risky event for the newborn. The mother-dependent respiration has to be replaced by a...
[english] Interruption of oxygen availability and re-oxygenation at birth implies a severe metaboli...
Interruption of oxygen availability and re-oxygenation at birth implies a severe metabolic insult, a...
Perinatal asphyxia (PA) is a relevant cause of death at the time of labour, and when survival is sta...
Perinatal asphyxia constitutes a prototype of obstetric complications occurring when pulmonary oxyg...
There is no established treatment for the long-term effects produced by perinatal asphyxia. Thus, we...
There is no established treatment for the longterm eVects produced by perinatal asphyxia. Thus, we ...
The present study shows that nicotinamide prevents the long-term eVect of perinatal asphyxia on do...
Asphyxia during birth can cause gross brain damage, but also subtle perturbations expressed as bioch...
Asphyxia during birth can cause gross brain damage, but also subtle perturbations expressed as bioch...
The potential neuroprotection of nicotinamide on the consequences of perinatal asphyxia was invest...
Background. Hypoxia ischemia (HI) to the developing brain occurs in 1–6 in 1000 live births. Large ...
Aminophylline is widely used in the management of premature apnea. The methylxanthines aminophylline...
© 2015, The Author(s).Perinatal asphyxia (PA) is a leading cause of neuronal damage in newborns, res...
We have investigated the idea that nicotinamide, a non-selective inhibitor of the sentinel enzyme Po...
Delivery is a risky event for the newborn. The mother-dependent respiration has to be replaced by a...
[english] Interruption of oxygen availability and re-oxygenation at birth implies a severe metaboli...
Interruption of oxygen availability and re-oxygenation at birth implies a severe metabolic insult, a...
Perinatal asphyxia (PA) is a relevant cause of death at the time of labour, and when survival is sta...
Perinatal asphyxia constitutes a prototype of obstetric complications occurring when pulmonary oxyg...
There is no established treatment for the long-term effects produced by perinatal asphyxia. Thus, we...
There is no established treatment for the longterm eVects produced by perinatal asphyxia. Thus, we ...
The present study shows that nicotinamide prevents the long-term eVect of perinatal asphyxia on do...
Asphyxia during birth can cause gross brain damage, but also subtle perturbations expressed as bioch...
Asphyxia during birth can cause gross brain damage, but also subtle perturbations expressed as bioch...
The potential neuroprotection of nicotinamide on the consequences of perinatal asphyxia was invest...
Background. Hypoxia ischemia (HI) to the developing brain occurs in 1–6 in 1000 live births. Large ...
Aminophylline is widely used in the management of premature apnea. The methylxanthines aminophylline...